During the last 40 years, studies incorporating in vitro methodologies have greatly advanced our understanding of human nerve cell biology. Attempts have been made to apply these to investigations of neurotoxicity. Due to the complexity of the nervous system, underpinned by an array of integrated interactions between a host of cell types, it is concluded that, at present, alternative neural models are most successful in determining the underlying mechanisms which can cause perturbation of normal functioning of the nervous system, both in adults and during the embryonic period. The use of tiered batteries of test models has been proposed in screening programmes for neurotoxicity, with the generation of much encouraging data in laboratories across the globe. This review aims to discuss the development of neural alternatives, considers the various model systems available, and highlights specific neuronal endpoints which can be tested, in addition to the cytotoxic evaluation of neuronal viability. Developments in molecular and stem cell biology, which are appropriate to neural tissue, and which offer the prospect of exciting advances for the next decade, are cited.
Anon. (1991). Animals and alternatives in toxicology: present status and future prospects. ATLA19, 116–138.
2.
WalumE., HanssonE. & HarveyA.L. (1990). In vitro testing of neurotoxicity. ATLA18, 153–179.
3.
AtterwillC.K., BruininkA., DrejerJ., DuarteE., AbdullaE.M., MeredithC., NicoteraP., Rodriquez-FarreE., SimpsonM.G., SmithR., VeronesiB., VijverbergH., WalumE. & WilliamsD.C. (1994). In vitro neurotoxicity testing. The report and recommendations of ECVAM Workshop 3. ATLA22, 350–362.
4.
WorthA.P. & BallsM. (2002). Alternative (non-animal) methods for chemical testing: Current status and future prospects. ATLA30 Suppl. 1, 1–125.
5.
CoeckeS., EskesC., GartlonJ., KinsnerA., PriceA., van VlietE., PrietoP., BoveriM., BremerS., AdlerS., PellizzerC., WendelA. & HartungT. (2006). The value of alternative testing for neurotoxicity in the context of regulatory needs. Environmental Toxicology & Pharmacology21, 153–167.
6.
Bal-PriceA.K., SunolC., WeissD.G., van VlietE., WesterinkR.H.S. & CostaL.G. (2008). Application of in vitro neurotoxicology testing for regulatory purposes: Symposium III summary and research needs. Neurotoxicology29, 520–531.
7.
Bal-PriceA.K., HogbergH.T., BuzanskaL. & CoeckeS. (2009). Relevance of in vitro neurotoxicology testing for regulatory requirements: Challenges to be considered. Neurotoxicology & Teratology, E-pub ahead of print, doi:10.1016/j.ntt2008.12.003.
8.
OECD (2007). Retrospective Performance Assessment of the Test Guideline 426 on Developmental Neurotoxicity, 25 pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: www.oecd.org/dataoecd/57/7/39824463.doc (Accessed 29.07.09).
9.
EPA (1998). Guidelines for Neurotoxicity Risk Assessment, Federal Register63(93):26926–26954, EPA/630/R-95/001F, 89pp. Washington, DC, USA: US Environmental Protection Agency, Risk Assessment Forum. Available at: http://www.epa.gov/ncea/raf/pdfs/neurotox.pdf (Accessed 29.07. 09).
10.
LillenblumW., DekantW., FothH., GebelT., HengstlerJ.G., KahlR., KramerP-J., SweinfurthH. & WollinK-M. (2008). Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Archives of Toxicology82, 211–236.
11.
GartlonJ., KinsnerA., Bal-PriceA., CoeckeS. & ClothierR.H. (2006). Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. Toxicology in Vitro20, 1569–1581.
12.
HarryG.J., BillingsleyM., BruininkA., CampbellI.L., ClassenW., DormanD.C., GalliC., RayD., SmithR.A. & TilsonH.A. (1998). In vitro techniques for the assessment of neurotoxicity. Environmental Health Perspectives106S1, 131–158.
13.
HarryG.J. & Tiffany-CastiglioniE. (2005). Evaluation of neurotoxic potential by use of in vitro systems. Expert Opinion on Drug Metabolism & Toxicology1, 701–713.
14.
ColemanM.D. (2006). Progress in the development of in vitro human-based alternatives to animal models. Environmental Toxicology & Pharmacology21, 120–122.
15.
TilsonH.A. & CabeP.A. (1978). Strategy for the assessment of neurobehavioural consequences of environmental factors. Environmental Health Perspectives26, 287–299.
16.
LeinP., LockeP. & GoldbergA. (2007). Meeting report: Alternatives for developmental neurotoxicity testing. Environmental Health Perspectives115, 764–768.
17.
CoeckeS., GoldbergA.M., AllenS., BuzanskaL., CalamandreiG., CroftonK., HarengL., HartungT., KnautH., HoneggarP., JacobsM., LeinP., LiA., MundyW., OwenD., SchneiderS., SilbergeldE., ReumT., TrnovecT., Monnet-TschudiF. & Bal-PriceA. (2007). Workgroup Report: Incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Environmental Health Perspectives115, 924–931.
18.
RadioN.M. & MundyW.R. (2008). Developmental neurotoxicity testing in vitro: Models for assessing chemical effects on neurite outgrowth. Neurotoxicology29, 361–376.
19.
CraftA.D. (2009). The slice culture model: Considerations for neurotoxicity assessment. In Nervous System: 3rd edition, Target Organ Toxicology Series (ed. HarryG.J. & TilsonH.A.), in press. Philadelphia, PA, USA: Taylor & Francis.
20.
BreierJ.M., RadioN.M., MundyW.R. & ShaferT.J. (2008). Development of a high-throughput screening assay for chemical effects on proliferation and viability of immortalised human neural progenitor cells. Toxicological Sciences105, 119–133.
21.
BhogalN., GrindonC., CombesR. & BallsM. (2005). Toxicity testing: creating a revolution based on new technologies. Trends in Biotechnology23, 299–307.
22.
ZurichM.G., HoneggarP., SchilterB., CostaL.G. & Monnet-TschudiF. (2000). Use of aggregating brain cell cultures to study developmental effects of organophosphorus insecticides. Neurotoxicology21, 599–605.
GoldoniM., VettoriM.V., AlinoviR., CaglieriA., CeccatelliS. & MuttiA. (2003). Models of neurotoxicity: Extrapolation of benchmark doses in vitro. Risk Analysis23, 505–514.
25.
SanfeliuC., CristofolR., ToranN., Rodriguez-FarreE. & KimS.U. (1999). Use of human central nervous system cell cultures in neurotoxicity testing. Toxicology in Vitro13, 753–759.
26.
PelkonenO., TurpeinenM., UusitaloJ., RautioA. & RaunioH. (2005). Prediction of drug metabolism and interactions on the basis of in vitro investigations. Basic & Clinical Pharmacology & Toxicology96, 167–175.
27.
ForsbyA. & BlaauboerB. (2007). Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity. Human & Experimental. Toxicology26, 333–338.
28.
Tiffany-CastiglioniE., EhrichM., DeesL., CostaL.G., KodavantiP.R.S., LasleyS.M., OortgiesenM. & DurhamH.D. (1999). Bridging the gap between in vitro and in vivo models for neuurotoxicology. Toxicological Sciences51, 178–183.
29.
SchubertD., HeinemannS., CarlisleW., TarikasB., KimesJ., BatrickJ., SteinbachJ.H., CulpW. & BrandtB.L. (1974). Clonal cell lines from the rat central nervous system. Nature, London249, 224–227.
30.
GreeneL.A. & TischlerA.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proceedings of the National Academy of Sciences of the USA73, 2424–2428.
31.
WesterinkR.H.S. (2004). Exocytosis: using amperometry to study presynaptic mechanisms of neurotoxicity. Neurotoxicology25, 461–470.
32.
Paquet-DurandF., TanT. & BickerG. (2003). Turning teratocarcinoma cells into neurons: rapid differentiation of NT-2 cells into floating spheres. Brain Research: Developmental Brain Research142, 161–167.
33.
TumilowiczJ.J., NicholsW.W., CholanJ.J. & GreeneA.E. (1970). Definition of a continuous human cell line derived from neuroblastoma. Cancer Research30, 2110–2118.
34.
ClementiF., CabriniD., GottiC., FornasariD. & SherE. (1987). A human neuroblastoma cell line for neurotxicity testing in vitro: Effects of heavy metals. Progress in Clinical & Biological Research253, 137–149.
35.
Perez-PoloJ.R., Werbach-PerezK. & Tiffany-CastiglioniE. (1979). A human clonal cell line model of differentiating neurons. Developmental Biology71, 341–355.
36.
NdountseL.T. & ChanH.M. (2008). Methyl-mercury increases N-methyl-D-aspartate receptors on human SH-SY5Y neuroblastoma cells leading to neurotoxcity. Toxicology249, 251–255.
37.
JungJ.E., MoonJ.Y., GhilS.H. & YooB.S. (2009). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibits neurite outgrowth in differentiating human SH-SY5Y neuroblastoma cells. Toxicology Letters188, 153–156.
38.
CheungY-T., LauW.K-W., YuM-S., LaiC.S-W., YeungS-C., SoK-F. & ChangR.C-C. (2009). Effects of all-trans retinoic acid on human SHSY5Y neuroblastoma as an in vitro model in neurotoxicity research. Neurotoxicology30, 127–135.
39.
Hallier-VanuxeemD., PrietoP., CulotM., DialloH., LandryC., TahtiH. & CecchelliR. (2009). New strategy for altering central nervous system toxicity: Integration of blood–brain barrier toxicity and permeability in neurotoxicity assessment. Toxicology in Vitro23, 447–453.
40.
ShaharA., de VellisJ., VernadakisA. & HaberB. (eds) (1989). A Dissection and Tissue Culture Manual of the Nervous System, 371 pp. New York, NY, USA: Alan R. Liss, Inc.
41.
SilvaR.F.M., FalcãoA.S., FernandesA., GordoA.C., BritoM.A. & BritesD. (2006). Dissociated primary nerve cell cultures as models for assessment of neurotoxicity. Toxicology Letters163, 1–9.
42.
SmithR.A. (1991). Primary cultures of adult mammalian sensory neurons and other in vitro systems of use in neurotoxicological studies. Archives of Toxicology: Supplement14, 8–14.
43.
SmithR.A. & JiangZ-G. (1994). Neuronal modulation and plasticity in vitro. International Review of Cytology153, 233–296.
44.
BaxterG.J. & SmithR.A. (1998). Changes in neuropeptide immunoreactivity in cultured adult mouse sensory neurons following methyl mercury chloride treatments. Neuroscience Letters246, 13–16.
45.
SweeneyM., CreanorS.L., SmithR.A. & FoyeR.H. (2002). The release of mercury from dental amalgam and potential neurotoxicological effects. Journal of Dentistry30, 243–250.
46.
KimJ.H, KimS.U. & KitoS. (1984). Immunocytochemical demonstration of β-endorphin and β-lipoprotein in cultured human spinal ganglion neurons. Brain Research304, 192–196.
47.
LobnerD. (2000). Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? Journal of Neuroscience Methods96, 147–152.
48.
BrewerG.J., TorricelliJ.R., EvegeE.K. & PriceP.J. (1993). Optimized survival of hippocampal neurons in B-27 supplemented Neurobasal, a new serum-free combination. Journal of Neuroscience Research35, 567–576.
49.
McCarthyK.D. & deVellisJ. (1980). Preparation of astroglial and oligodenroglial cell cultures from rat cerebral tissue. Journal of Cell Biology85, 890–902.
50.
HarryG.J. & CraftA.D. (2008). Neuro-inflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opinion on Drug Metabolism & Toxicology4, 1265–1277.
51.
FujimuraM., UsukiF., SawadaM., RosteneW., GodefroyD. & TakashimaA. (2009). Methylmercury exposure downregulates the expression of RacI and leads to neuritic degeneration and ultimately apoptosis in cerebrocortical neurons. Neurotoxicology30, 16–22.
52.
RushT., HjelmhaugJ. & LobnerD. (2009). Effects of chelators on mercury, iron, lead neurotoxicity in cortical culture. Neurotoxicology30, 47–51.
53.
SunolC., BabotZ., FonfriaE., GalofreM., GarciaD., HerreraN., IraolaS. & VendrellI. (2008). Studies with neuronal cells: from basic studies of mechanisms of neurotoxicity to the prediction of chemical toxicity. Toxicology in Vitro22, 1350–1355.
54.
KodavantiP.R.S., MundyW.R., TilsonH.A. & HarryG.J. (1993). Effects of selected neuroactive chemicals on calcium transporting systems in rat cerebellum and on survival of cerebellar granule cells. Fundamental & Applied Toxicology21, 308–316.
55.
MalcolmC.S., BenwellK.R., LambH., BebbingtonD. & PorterR.H.P. (2000). Characterisation of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells. Free Radical Biology & Medicine28, 102–107.
56.
SmithR.A., WalkerT., XieX. & HouS.T. (2003). Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Molecular Brain Research116, 70–79.
57.
FatokunA.A., StoneT.W. & SmithR.A. (2007). Cell death in rat cerebellar granule neurones induced by hydrogen peroxide in vitro: mechanisms and protection by adenosine receptor ligands. Brain Research1132, 193–202.
58.
SmithA.J., SmithR.A., StoneT.W. (2009). 5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurons. Neurotoxicity Research15, 303–310.
59.
Al-GonaiahM.A., SmithR.A. & StoneT.W. (2009). Xanthine oxidase-induced neuronal death via the oxidation of NADH: prevention by micro-molar EDTA. Brain Research1280, 33–42.
60.
AtterwillC.K. (1989). Brain re-aggregate cultures in neurotoxicological investigations: studies with cholinergic neurotoxins. ATLA16, 221–230.
61.
DehouckM.P., MeresseS., DelormeP., FruchartJ.C. & CecchelliR. (1990). An easier, reproducible, and mass-production method to study the blood–brain barrier in vitro. Journal of Neurochemistry54, 1798–1801.
62.
PrietoP., BlauboerB.J., De BoerA.G., BoveriM., CechelliR., ClemedsonC., CoeckeS., ForsbyA., GallaH.J., GarbergP., GreenwoodJ., PriceA. & TahtiH. (2004). Blood–brain barrier in vitro models and their application to toxicology. The report and recommendations of ECVAM Workshop 49. ATLA32, 37–50.
63.
ToimelaT., MaenpaaH., MannerstromM. & TahtiH. (2004). Development of an in vitro blood–brain model — cytotoxicity of mercury and aluminium. Toxicology & Applied Pharmacology195, 73–82.
64.
Tiffany-CastiglioniE., HongS., QianY., TangY. & DonnellyK.C. (2006). In vitro models for assessing neurotoxicity of mixtures. Neurotoxicology27, 835–839.
65.
CulotM., LundquistS., VanuxeemD., NionS., LandryC., DelplaceY., DehouckM.P., BereowskiV., FenartL. & CecchelliR. (2008). An in vitro blood–brain barrier model for high throughput (HTS) toxicological screening. Toxicology in Vitro22, 799–811.
66.
MannerstromM., ToimelaT., YlikomiT. & TahtiH. (2006). The combined use of human neural and liver cell lines and mouse hepatocytes improves the permeability of the neurotoxicity of selected drugs. Toxicology Letters165, 195–202.
67.
GahwilerB.H. (1981). Organotypic monolayer cultures of nervous tissue. Journal of Neuroscience Methods4, 329–342.
68.
FountainS.B. & TeylerT.J. (1987). Characterising neurotoxicity using the in vitro hippocampal brain slice preparation: heavy metals. Progress in Clinical & Biological Research253, 19–31.
69.
GahwilerB.H., CapognaM., DebanneD., McKinneyR.A. & ThompsonS.M. (1997). Organotypic slice cultures: a technique has come of age. Trends in Neuroscience20, 471–477.
70.
BallatoriN. & VillalobosA.R. (2002). Defining the molecular and cellular basis of toxicity using comparative models. Toxicology & Applied Pharmacology183, 207–220.
71.
LuengM.C.K., WilliamsP.L., BenedettoA., AuC., HelmckeK.J., AschnerM. & MeyerJ.N. (2008). Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicological Sciences106, 5–28.
72.
PetersonR.T., NassR., BoydW.A., FreedmanJ.H., DongK. & NarahashiT. (2008). Use of non-mammalian alternative models for neurotoxicological study. Neurotoxicology29, 546–555.
73.
ColeR.C., AndersonG.L. & WilliamsP.L. (2004). The nematode Caenorhabditis elegans as a model of organophosphate-induced mammalian neurotoxicity. Toxicology & Applied Pharmacology194, 248–256.
BoydW.A, SmithM.V., KisslingG.E. & FreedmanJ.H. (2009). Medium- and high-throughput screening of neurotoxciants using C. elegans. Neurotoxicology & Teratology, E-pub ahead of print, doi:10.1016/j.ntt2008.12.004.
76.
DongW., TeraokaH., YamazakiK., TsukiyamaS., ImaniS., ImagawaT., StegmanJ.J., PetersonR.E. & HiragaT. (2002). 2,3,7,8-tetra-chlorodibenzo-p-dioxin toxicity in the zebrafish embryo: Local circulation failure in the dorsal midbrain is associated with increased apoptosis. Toxicological Sciences69, 191–201.
77.
StokesE.A., LonerganW., WeberL.P., JanzD.M., PozanskiA.A., BalchG.C., MetcalfeCD. & GroberM.S. (2004). Decreased apoptosis in the forebrain of adult male medaka (Oryzias lapites) after aqueous exposure to ethinylestradiol. Comparative Biochemistry & Physiology — Part C: Toxicology & Pharmacology138, 163–167.
78.
CostaL. (1998). Biochemical and molecular neurotoxicology: relevance to biomarker development, neurotoxicity testing and risk assessment. Toxicology Letters102–103, 417–421.
79.
HouS.T., JiangS.X. & SmithR.A. (2008). Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. International Review of Cell & Molecular Biology267, 125–181.
80.
CummingR., BurgoyneR.D. & LyttonN.A. (1984). Immunofluorescence distribution of α-tubulin, β-tubulin and microtubule-associated protein 2 during in vitro maturation of cerebellar neurones. Neuroscience12, 775–782.
81.
AbdullaE.M. & CampbellI.C. (1993). Use of neurite outgrowth as an in vitro method of assessing neurotoxicity. Annals of the New York Academy of Sciences679, 276–279.
82.
BilslandJ., RigbyM., YoungL. & HarperS. (1999). A rapid method for semi-quantitative analysis of neurite outgrowth from chick DRG explants using image analysis. Journal of Neuroscience Methods92, 75–85.
83.
CarrierR.L., MaT.C., ObrietanK. & HoytK.R. (2006). A sensitive and selective assay of neuronal degeneration in cell culture. Journal of Neuroscience Methods154, 239–244.
84.
MundyR., RobinetteB., RadioN.M. & FreudenrichT.M. (2008). Protein biomarkers associated with growth and synaptogenesis in a cell culture model of neuronal development. Toxicology249, 220–229.
85.
BratD.J. & BrimijoinS. (1993). Acrylamide and glyceride impair neurite outgrowth in differentiating N1E 115 neuroblastoma without disturbing rapid bi-directional transport of organelles observed by video microscopy. Journal of Neurochemistry60, 2145–2152.
86.
HogbergH.T., Kinsner-OvaskainenA., HartungT., CoeckeS.S. & Bal-PriceA.K. (2009). Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. Toxicology & Applied Pharmacology235, 268–286.
87.
BabotZ., VilaroM.T. & SunolC. (2007). Long-term exposure to dieldrin reduces γ-aminobutyric acid type A and N-methyl-D-aspartate receptor function in primary cultures of mouse cerebellar granular cells. Journal of Neuroscience Research85, 3687–3695.
88.
GalofreM., BabotZ., GarciaD.A., IraolaS., Rodriguez-FarreE., ForsbyA. & SunolC. (2009). GABAA receptor and cell membrane potential as functional endpoints in cultured neurons to evaluate chemicals for human acute toxicity. Neurotoxicology & Teratology, E-pub ahead of print, doi:10.1016/j.ntt2009.01.010.
89.
GunasekarP., LiL., PrabhakaranK., EyblV., BorowitzJ.L. & IsomG.E. (2001). Mechanisms of the apoptotic and necrotic actions of trimethyltin in cerebellar granule cells. Toxicological Sciences64, 83–89.
90.
ChebaboS.R., SantosM.D. & AlbuquerqueE.X. (1999). The organophosphate sarin, at low concentrations, inhibits the evoked release of GABA in rat hippocampal slices. Neurotoxicology20, 871–882.
91.
MeyerD.A., CarterJ.M., JohnstoneA.F. & ShaferT.J. (2008). Pyrethroid modulation of spontaneous neuronal excitability and neurotransmission in hippocampal neurons in culture. Neurotoxicology29, 213–225.
92.
ChenL., LiuL., YinY. & HuangS. (2009). Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. International Journal of Biochemistry & Cell Biology41, 1284–1295.
93.
FatokunA.A., StoneT.W. & SmithR.A. (2008). Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons. Experimental Brain Research186, 151–160.
94.
BernauerU., OberemmA., MadleS. & Gundert-RemyU. (2005). The use of in vitro data in risk assessment. Basic & Clinical Pharmacology & Toxicology96, 176–181.
95.
Simon-HettichB., RothfussA. & Steger-HartmannT. (2006). Use of computer-assisted prediction of toxic effects of chemical substances. Toxicology224, 156–162.
96.
LoPachinR.M., JonesR.C., PattersonT.A., SlikkerW.Jr & BarberD.S. (2003). Application of proteomics to the study of molecular mechanisms in neurotoxicology. Neurotoxicology24, 761–775.
97.
HarryG.J. (2004). Emerging technologies in neurotoxicology: Session III summary and research needs. Neurotoxicology25, 503–506.
98.
LubecG., KrapfenbauerK. & FountoulakisM. (2003). Proteomics in brain research: potentials and limitations. Progress in Neurobiology69, 193–211.
99.
SchwartzP.H., BrickD.J., StoverA.E., LoringJ.F. & MullerF-J. (2008). Differentiation of neural lineage cells from human pluripotent stem cells. Methods45, 142–158.
100.
AdlerS., PellizzerC., HarengL., HartungT. & BremerS. (2008). First steps in establishing a developmental toxicity test method based on human embryonic stem cells. Toxicology in Vitro22, 200–211.
